Esgipyrin-A Tablet is a combination analgesic and anti-inflammatory medication containing Aceclofenac 100 mg and Paracetamol 325 mg, indicated for the relief of mild to moderate pain and inflammation associated with musculoskeletal disorders such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), exerts its effect by selectively inhibiting cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing the synthesis of prostaglandins responsible for pain and inflammation. Paracetamol complements this action by providing analgesic and antipyretic effects through central inhibition of prostaglandin synthesis. The combination enhances therapeutic efficacy while minimizing the dose-related adverse effects commonly seen with higher doses of individual agents. Esgipyrin-A is typically administered orally, with dosage tailored according to the severity of symptoms and patient response. Caution is advised in patients with a history of gastrointestinal ulcers, hepatic or renal impairment, and cardiovascular diseases. Common side effects may include gastrointestinal discomfort, nausea, and dizziness. It is contraindicated in patients with known hypersensitivity to Aceclofenac, Paracetamol, or other NSAIDs. Regular monitoring and adherence to prescribed dosage are essential to ensure safety and optimal therapeutic outcomes.